New multiple myeloma drug faces off against standard treatment in 258-Patient trial
NCT ID NCT07477587
First seen Mar 19, 2026 · Last updated May 17, 2026 · Updated 5 times
Summary
This study tests whether a new drug called HLX15-SC works as well as the approved drug DARZALEX FASPRO® for people newly diagnosed with multiple myeloma who cannot have a stem cell transplant. About 258 participants will receive either the new drug or the approved one, along with standard medications, for up to 32 weeks. The goal is to compare how the drugs are processed in the body, their safety, and their effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
American Oncology Network Vista Oncology Division / Physician partner associate
Olympia, Washington, 98506, United States
-
Cancer Specialists of North Florida
Jacksonville, Florida, 32256, United States
-
D&H National Research Center
Margate, Florida, 33063, United States
-
Florida Clinical Trials Group
Plantation, Florida, 33322, United States
-
Florida Clinical Trials Group
Tamarac, Florida, 33321, United States
-
Highlands Oncology Group, PA
Springdale, Arkansas, 72762, United States
-
Oncology Consultants (P1 Trials -Exigent Network)
Houston, Texas, 77030, United States
-
Pontchartrain Cancer Center
Covington, Louisiana, 70433, United States
-
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.